730. T Cell Responses to AAV Vector Capsid in Normal Donors and Subjects Who Have Undergone Liver-Directed AAV-Mediated Gene Transfer
Marcela V. Maus(Center for Cancer Research), Katherine A. High(Spark Therapeutics (United States)), Daniel J. Hui(Children's Hospital of Philadelphia), Denise E. Sabatino(Children's Hospital of Philadelphia), Margaret V. Ragni(University of Pittsburgh Medical Center), Federico Mingozzi(Spark Therapeutics (United States))
Cited by 1
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Gene therapy comes of age
|Science|2018|1.4k